indazoles has been researched along with Central Nervous System Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asthagiri, AR; Chen, CJ; Ilyas, A; Mehta, GU; Oldfield, EH; Schiff, D; Taylor, DG | 1 |
| Alentorn, A; Apra, C; Kalamarides, M; Mokhtari, K; Sanson, M | 1 |
| Debatin, KM; Enzenmüller, S; Fulda, S; Gonzalez, P; Karpel-Massler, G | 1 |
3 other study(ies) available for indazoles and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Indazoles; Kidney Neoplasms; Male; Pyrimidines; Sulfonamides; von Hippel-Lindau Disease | 2018 |
Pazopanib efficacy in recurrent central nervous system hemangiopericytomas.
Topics: Adult; Angiogenesis Inhibitors; Central Nervous System Neoplasms; Female; Hemangiopericytoma; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines; Solitary Fibrous Tumors; Sulfonamides; Treatment Outcome | 2018 |
GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; bcl-2-Associated X Protein; Betulinic Acid; Caspase 3; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Glioblastoma; Humans; Indazoles; Intracellular Membranes; Lysosomes; Matrix Metalloproteinases; Pentacyclic Triterpenes; Permeability; Sulfonamides; Triterpenes | 2013 |